Overview
Noramco specializes in the development and cGMP manufacturing of specialty active pharmaceutical ingredients (APIs), with a focus on controlled substances including opioids, stimulants, and cannabinoids. The company offers end-to-end solutions from narcotic raw materials and intermediates to multi-ton commercial supplies, supported by DEA-compliant processes in facilities across the United States and Europe. Additional services include custom synthesis, pre-formulation studies, particle sizing, stability assessments, and supply chain integration for pharmaceutical procurement and R&D.
Frequently asked questions
- What are Noramco's core manufacturing capabilities for controlled substances?
- Noramco provides cGMP production of controlled-substance APIs from kilos to multi-ton scales, including opioids, stimulants like methylphenidate, and cannabinoids, with custom particle sizing and formulation support at facilities in the US (Delaware) and Europe.
- What regulatory compliance does Noramco offer?
- Noramco delivers DEA-compliant security and production for Schedule I to III substances, with comprehensive regulatory support, global regulatory footprint, and expertise in quality by design integrated into API development and manufacturing.
- What geographies does Noramco operate in?
- Noramco operates cGMP facilities in the United States (headquartered in Delaware) and Europe, sourcing from patented poppies via Tasmanian Alkaloids, and supplies world markets with high-purity APIs.